Tenomix secures an all-Canadian oversubscribed Seed round of $2M to advance a breakthrough cancer care robotics system

Tenomix, a pioneering medical technology company at Velocity, University of Waterloo’s startup incubator, successfully closed a $2 million all-Canadian seed funding round that will help develop a groundbreaking robotics system designed improve the accuracy of colon cancer staging.

Accurate determination of colorectal cancer stages is crucial to determining the right treatment plan but is often a delicate balance between art and science. Tenomix has invented a robot that uses ultrasound and artificial intelligence to automate the current manual lymph node screening process and significantly improves cancer staging accuracy.

We are very happy to support Tenomix through OBIO’s Women in Health Initiative Seed Program! Tenomix is an alumnus of our BDSP™ and HealthMINT™ programs and presented at the OBIO® Investment Summit.